Abstract
### Key points Advanced pharmacokinetic models for target-controlled infusion (TCI) have facilitated an increasing use of total i.v. anaesthesia (TIVA) in various clinical settings. The technical complexity and labour-intensive methodology of TIVA can deter clinicians and lead to default use of a volatile agent. In theory, any combination of i.v. hypnotic(s) and opioid(s) can be used and opioid-free techniques are described. In practice, the synergy between TCI infusions of propofol and remifentanil proves highly effective at obtunding response to noxious stimuli1 and for this article constitutes ‘ideal’ TIVA. This drug combination achieves equilibrium between adequate depth of anaesthesia and rapid recovery. Intermittent boluses of agents or manually controlled infusions may produce an inadequate effect.2 The specific indications for TIVA are given in Table 1. TIVA is applicable to nearly all types of surgery but has particular value in clinical scenarios where a stress-free awake extubation free of laryngospasm is required. TIVA confers many advantages over a conventional volatile technique, particularly a better recovery profile with reduced risk of postoperative nausea and vomiting, and can facilitate intraoperative wake-up while retaining amnesia. The use of TIVA for cases requiring a rapid intubation sequence is controversial but is safely practiced. View this table: Table 1 Specific indications for …
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.